Work

GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models

Year: 2020

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-020-05558-w

Authors: Shanchun Guo, Changde Zhang, Madhusoodanan Mottamal, Ahamed Hossain, Jiawang Liu, Guangdi Wang

Institutions: Xavier University of Louisiana, University of Tennessee Health Science Center

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute on Minority Health and Health Disparities

Awards: Xavier RCMI Center for Cancer Research , IND-Enabling Studies of ZB716, an Orally Bioavailable SERD, IND-Enabling Studies of ZB716, an Orally Bioavailable SERD, The RCMI Center for Cancer and Health Disparities Research

OpenAlex ID: W3005331379

FWCI: 1.172

Cites: 38

Cited by: 13

Related to: 10